Exciting progress has been made in the first human stem cell therapy trial, raising hopes for a new approach to treating Alzheimer’s and potentially aiding in brain repair. The Phase 1 study is focused on determining the optimal dosage for a future Phase 2 trial. Regeneration Biomedical, the company behind the research, plans to expand the therapy to address other conditions like multiple sclerosis, Parkinson’s disease, traumatic brain injury, and amyotrophic lateral sclerosis. For more details on this groundbreaking research, contact Regeneration Biomedical through their website or phone number provided.
Read more about this — here
